Navigation Links
LSTM begins £0.5 million malaria study in Burkina Faso
Date:2/3/2010

A new study led by LSTM will investigate whether long-term weekly iron and folic acid supplementation can reduce anaemia without increasing the risk of contracting malaria. The information provided by the study, based in Burkina Faso and running until 2014, will strengthen adolescent health services and develop effective preventative programmes for anaemia control in young women.

Young women who conceive during or shortly after adolescence may enter pregnancy with deficient iron stores due to their development and the onset of menstruation. This can be offset with iron supplementation but there is some evidence that this can increase the risk of contracting malaria. Many young women tend not to present at antenatal clinics until mid-pregnancy and are therefore unlikely to be protected from malaria at the most susceptible period in early pregnancy.

Professor Bernard Brabin, Head of LSTM's Child and Reproductive Health department, has secured a 0.5 million grant from the US National Institutes of Health, through support from the Bill & Melinda Gates Foundation, to test the hypothesis that iron supplementation in young women prior to conception and during early pregnancy results in reduced iron deficiency and anaemia in pregnancy without increasing malaria risk. The study is being conducted in partnership with the Centre Muraz in Burkina Faso and the Institute of Tropical Medicine in Antwerp.

Professor Brabin explained: "As young women who are pregnant for the first time are particularly susceptible to the risks of malaria in pregnancy, it is essential to assess the safety of long term weekly supplementation, an approach now recommended by the World Health Organization. Some fifty million pregnant women are at risk of malaria every year but there are only four published studies of the effects of iron treatments during pregnancy on the prevalence of both malaria and anaemia and none on malaria risks in early pregnancy."

T
'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
44-151-705-3308
Liverpool School of Tropical Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
3. DHS Begins Collecting 10 Fingerprints From International Visitors at Washington Dulles International Airport
4. UC San Diego begins trading greenhouse gas credits on Chicago Climate Exchange
5. DHS Begins Collecting 10 Fingerprints From International Visitors at Hartsfield-Jackson Atlanta International Airport
6. Exploration of lake hidden beneath Antarcticas ice sheet begins
7. DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport
8. DHS Begins Collecting 10 Fingerprints From International Visitors at Chicago OHare International Airport
9. DHS Begins Collecting 10 Fingerprints From International Visitors at George Bush Houston Intercontinental Airport
10. DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport
11. DHS Begins Collecting 10 Fingerprints From International Visitors at Miami International Airport
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
(Date:3/10/2015)... , March 10, 2015   Tute Genomics , ... been selected by next-generation sequencing company PrimBio Research ... exome and targeted gene panel interpretation. PrimBio, ... adopted the most current technologies to support the work ... The company offers two types of exome sequencing services: ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... lacking a special protein found only in germ-line cells ... to a new study from researchers at the University ... of Human Reproduction in Penn's Center for Research in ... investigations point the way to a new type of ...
... In a recent study published in the Journal of ... to play a purely structural and inert role in ... Using antagonists for this molecule, the researchers were able ... drug treatment. , The research appears as the "Paper ...
... of neuroscientists have been indoctrinated into believing that ... by a communication network of brain cells, or ... message called a neurotransmitter. Either neurons release a ... an electrical discharge and enhancing brain activity, or ...
Cached Biology News:Of mice and men's (and women's) contraceptives 2New polysaccharide may help combat multidrug resistance in cancer 2Researchers make surprise discovery that some neurons can transmit three signals at once 2Researchers make surprise discovery that some neurons can transmit three signals at once 3
(Date:3/25/2015)... BLOOMINGTON, MN (PRWEB) March 25, 2015 ... a breakthrough in nanoparticle technology that will enable ... and many other diseases with a simple breath ... ahead on the U.S. Food and Drug Administration ... 2016 launch of the innovative Nanoparticle Biomarker Tagging ...
(Date:3/25/2015)... /CNW/ - The Gairdner Foundation is pleased to ... recognizing some of the most significant medical discoveries ... the world,s most esteemed medical research prizes, the ... a $100,000 (CDN) prize to each scientist for their work. ... and innovation across the country, inspiring the next ...
(Date:3/25/2015)... 2015 Proove Biosciences , a ... to announce the success of their commercially supported symposium, ... to Optimize the Management of Pain, at the 31st ... Harbor, Maryland on Thursday, March 19th, 2015. ... President Lynn Webster , M.D., former Florida Society ...
(Date:3/25/2015)... 25, 2015 Oxis International, Inc. (OXIS) (OXI.PA) ... commercialization, announced today Oxis CEO Tony Cataldo ... 2015 at 4:15pm EST to update shareholders and other ...     Oxis Chairman and CEO Tony ... been very exciting for Oxis and our shareholders. There ...
Breaking Biology Technology:Ancon Medical Researchers Make Nanotechnology Breakthrough for Disease Screening Technology 2Ancon Medical Researchers Make Nanotechnology Breakthrough for Disease Screening Technology 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 22015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 42015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 52015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 62015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 72015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 8Proove Biosciences Hosts Symposium on Incorporating Genetic Testing to Optimize the Management of Pain 2Oxis Biotech Inc. Announces Corporate Update Conference Call for March 31 2
... (OTC:,SPOM - News), a leading developer of biosensor and ... that it,has appointed Med Tech and Med Care Associates ... market. , Med Tech and ... healthcare industry and operate with manufacturers,of medical products and ...
... Md., Feb. 17 Human Genome Sciences, Inc. (Nasdaq: ... GSK ) has initiated a Phase 3 ... tolerability of Syncria (R) (albiglutide) in the long-term ... result, HGS will receive a $9 million milestone payment ...
... at the 19th Conference of the Asian Pacific ... Demonstrated Favorable Pharmacokinetics and Significant Reduction in Viral ... privately held biopharmaceutical company, today announced results from ... a controlled release version of nitazoxanide in the ...
Cached Biology Technology:SPO Medical Appoints New US Sales Rep Groups 2SPO Medical Appoints New US Sales Rep Groups 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 2Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 3Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 4
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... gap filling, localized cloning of genomic DNA, ...
Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
...
Biology Products: